https://wokeph.com/files/example-asx-post/2022-01-18T00:53:58+11:00https://wokeph.com/files/aenean-lacinia-bibendum-nulla-sed-consectetur/2022-01-18T00:53:54+11:00https://wokeph.com/files/vivamus-sagittis-lacus-vel-augue-laoreet-rutrum-faucibus-dolor-auctor/2022-01-18T00:53:52+11:00https://wokeph.com/files/donec-id-elit-non-mi-porta-gravida-at-eget-metus/2022-01-18T00:53:48+11:00https://wokeph.com/files/cum-sociis-natoque-penatibus-et-magnis-dis-parturient-montes-nascetur-ridiculus-mus/2022-01-18T00:53:55+11:00https://wokeph.com/files/example-video/2022-01-18T00:53:46+11:00https://wokeph.com/files/cy2022-ceo-corporate-overview/2022-02-01T17:45:03+11:00https://wokeph.com/files/woke-pharmaceuticals-launches-new-website/2022-02-01T15:34:44+11:00https://wokeph.com/files/woke-signs-letter-of-intent-with-idt-australia-for-manufacture-of-novel-psilocybin-dosage-forms/2022-02-02T11:48:11+11:00https://wokeph.com/files/woke-imports-psilocybin-from-purisys-in-the-us-for-formulation-of-novel-dosage-forms/2022-02-02T23:58:15+11:00https://wokeph.com/files/woke-signs-letter-of-intent-with-the-university-of-western-australia-to-identify-novel-lsd-analogues/2022-02-15T19:02:34+11:00https://wokeph.com/files/woke-expands-partnership-with-monash-university-to-develop-novel-psilocybin-formulation-for-treatment-resistant-depression/2022-03-02T12:15:50+11:00https://wokeph.com/files/woke-signs-manufacturing-agreement-with-idt-australia-for-novel-psilocybin-formulations-to-treat-depression/2022-04-07T10:47:13+10:00https://wokeph.com/files/woke-enters-clinical-agreement-with-macquarie-university-for-wp001-low-dose-psilocybin-for-moderate-depression/2022-04-26T15:33:35+10:00https://wokeph.com/files/macquarie-university-sydney-australia-clinical-trial-to-test-psychedelics-in-treating-depression/2022-04-26T15:59:13+10:00https://wokeph.com/files/woke-announces-first-shipment-of-natural-health-products-from-havn-life-sciences/2022-05-04T12:07:28+10:00https://wokeph.com/files/could-psychedelic-drugs-be-the-key-to-treating-mental-health-issues/2022-05-19T12:50:21+10:00https://wokeph.com/files/wokeph-and-monash-complete-wp001-psilocybin-formulation/2022-06-02T14:38:16+10:00https://wokeph.com/files/woke-and-university-of-western-australia-collaborate-to-discover-lsd-analogues/2022-06-09T13:52:42+10:00https://wokeph.com/files/woke-and-uwa-enter-agreement-to-identify-novel-lsd-analogues/2022-06-10T18:48:16+10:00https://wokeph.com/files/elon-musk-has-joined-the-celebrity-support-for-psychedelics/2022-06-13T11:27:29+10:00https://wokeph.com/files/can-microdosing-psychedelics-improve-your-mental-health-heres-what-the-science-says/2022-07-11T11:02:56+10:00https://wokeph.com/files/potential-therapeutic-benefits-of-psychedelics/2022-08-03T22:12:52+10:00https://wokeph.com/files/woke-highlights-morgan-stanley-report-on-psychedelics/2022-08-03T22:24:02+10:00https://wokeph.com/files/woke-and-qimr-berghofer-sign-letter-of-intent-for-clinical-trial-of-wp002-psilocybin-in-prolonged-grief/2022-08-11T19:02:04+10:00https://wokeph.com/files/woke-and-swinburne-university-sign-memorandum-of-understanding-to-develop-wp002-psilocybin-assisted-psychotherapy-phase-iib-trial-in-treatment-resistant-depression/2022-08-15T17:57:04+10:00https://wokeph.com/files/provisional-patent-application/2022-08-18T15:30:55+10:00https://wokeph.com/files/woke-setting-sights-on-australian-ipo-in-2023/2022-10-10T11:36:28+11:00https://wokeph.com/files/woke-and-university-of-sydney-sign-term-sheet-for-phase-ii-trial-of-wp002-psilocybin-in-alcohol-use-disorder/2022-10-18T00:10:31+11:00https://wokeph.com/files/biotech-daily-dr-borehams-crucible-on-woke/2022-10-24T16:45:17+11:00https://wokeph.com/files/woke-and-university-of-sydney-sign-clinical-trial-agreement-for-phase-iib-trial-of-wp002-psilocybin-in-alcohol-use-disorder/2022-12-11T22:31:38+11:00https://wokeph.com/files/woke-enters-clinical-agreement-with-qimr-berghofer-to-evaluate-wp002-psilocybin-for-prolonged-grief/2022-12-17T20:19:31+11:00https://wokeph.com/files/woke-and-curtin-university-sign-letter-of-intent-for-phase-ii-trial-of-wp002-psilocybin-in-musculoskeletal-pain/2022-12-19T13:19:38+11:00https://wokeph.com/files/trial-to-explore-the-use-of-psychedelics-for-alcohol-use-disorder/2022-12-22T19:03:01+11:00https://wokeph.com/files/australias-biggest-research-trial-using-psychedelics-to-treat-depression-to-commence-in-2023-swinburne-university-of-technology/2023-01-30T16:02:28+11:00https://wokeph.com/files/woke-welcomes-psilocybin-down-scheduling/2023-02-05T16:52:54+11:00https://wokeph.com/files/woke-enters-clinical-agreement-with-curtin-university-to-evaluate-wp002-psilocybin-for-chronic-pain/2023-02-16T00:07:31+11:00https://wokeph.com/files/australia-is-about-to-legalise-mdma-and-psilocybin-for-medicinal-use-so-how-will-it-work/2023-03-03T15:19:44+11:00https://wokeph.com/files/ethics-approval-received-for-world-first-phase-ii-trial/2023-07-14T09:35:46+10:00https://wokeph.com/files/university-of-western-australia-discovers-new-lsd-compounds/2024-03-12T16:31:46+11:00https://wokeph.com/files/update-on-australias-largest-psychedelics-trial-focused-on-treatment-resistent-depression/2024-05-28T22:44:23+10:00https://wokeph.com/files/macquarie-university-recruits-first-patients-for-australias-largest-psychedelic-focused-clinical-trial/2024-06-20T17:28:18+10:00https://wokeph.com/files/woke-extends-research-partnership-with-university-of-western-australia-following-discovery-of-55-new-lsd-compounds/2024-09-20T11:23:34+10:00https://wokeph.com/files/woke-pharmaceuticals-and-uwa-file-a-provisional-patent-for-new-simplified-lsd-analogues/2024-11-05T16:10:29+11:00https://wokeph.com/files/shareholder-announcement-macquarie-university-microdep-trial-set-to-enter-next-phase-of-research/2025-04-15T10:33:33+10:00https://wokeph.com/files/shareholder-announcement-the-university-of-sydney-executes-site-agreement-to-progress-phase-ii-clinical-trial-into-alcohol-use-disorder/2025-11-24T18:02:02+11:00